TY - JOUR
T1 - Chronic Pruritus and Connective Tissue Disorders
T2 - Review, Gaps, and Future Directions
AU - Haber, Jessica Sue
AU - Valdes-Rodriguez, Rodrigo
AU - Yosipovitch, Gil
N1 - Publisher Copyright:
© 2016, Springer International Publishing Switzerland.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Chronic itch is a common skin manifestation in many connective tissue diseases. However, the cause of chronic itch in these diseases is still not fully understood. The complex, and in some cases incomplete understanding of, pathogenesis in each condition makes it difficult to target specific mediators of chronic itch. It is important to better understand the pathophysiology of chronic itch in these conditions, as this information might provide a fuller understanding of the pathogenesis of the diseases in general and lead to the development of more specific treatments for connective tissue diseases in patients with chronic itch. We present a review of the literature on what is known about the prevalence, possible pathophysiology, and effect on quality of life of chronic itch in patients with scleroderma, Sjögren’s syndrome, dermatomyositis, systemic lupus erythematosus, cutaneous lupus erythematosus, and mixed connective tissue disease.
AB - Chronic itch is a common skin manifestation in many connective tissue diseases. However, the cause of chronic itch in these diseases is still not fully understood. The complex, and in some cases incomplete understanding of, pathogenesis in each condition makes it difficult to target specific mediators of chronic itch. It is important to better understand the pathophysiology of chronic itch in these conditions, as this information might provide a fuller understanding of the pathogenesis of the diseases in general and lead to the development of more specific treatments for connective tissue diseases in patients with chronic itch. We present a review of the literature on what is known about the prevalence, possible pathophysiology, and effect on quality of life of chronic itch in patients with scleroderma, Sjögren’s syndrome, dermatomyositis, systemic lupus erythematosus, cutaneous lupus erythematosus, and mixed connective tissue disease.
UR - http://www.scopus.com/inward/record.url?scp=84989237127&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84989237127&partnerID=8YFLogxK
U2 - 10.1007/s40257-016-0201-9
DO - 10.1007/s40257-016-0201-9
M3 - Article
C2 - 27260190
AN - SCOPUS:84989237127
SN - 1175-0561
VL - 17
SP - 445
EP - 449
JO - American Journal of Clinical Dermatology
JF - American Journal of Clinical Dermatology
IS - 5
ER -